Insurance coverage associated with improved cancer-specific outcomes

This article originally appeared here.
Insurance Coverage Tied to Better Cancer-Specific Outcomes
Insurance Coverage Tied to Better Cancer-Specific Outcomes

(HealthDay News) -- Health insurance coverage is associated with improved cancer-specific outcomes for young adults, according to a study published online June 2 in the Journal of Clinical Oncology.

Ayal A. Aizer, M.D., M.H.S., from the Harvard Radiation Oncology Program in Boston, and colleagues examined the correlation between insurance status and cancer-specific outcomes in young adults. Data were obtained from the Surveillance, Epidemiology, and End Results program for 39,447 patients aged 20 to 40 years and diagnosed with a malignant neoplasm between 2007 and 2009.

The researchers found that uninsured patients were more likely to be younger, male, nonwhite, and unmarried, and were also more likely to be from regions of lower income, education, and population density than insured patients (P < 0.001 in all cases). Insurance coverage correlated with decreased likelihood of presentation with metastatic disease (odds ratio, 0.84; P = 0.003); increased receipt of definitive treatment (odds ratio, 1.95; P < 0.001); and decreased any-cause death (hazard ratio, 0.77; P = 0.002), after adjustment for relevant confounding variables.

"The improved coverage fostered by the Affordable Care Act may translate into better outcomes among most young adults with cancer," the authors write.

Several authors disclosed financial ties to the biopharmaceutical and medical technology industries.

Abstract
Full Text (subscription or payment may be required)
Editorial

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs